AstraZeneca (AZN)

Sector:

Pharma and Biotech

Index:

FTSE 100

14,052.00p
   
  • Change Today:
      26.00p
  • 52 Week High: 14,346.00
  • 52 Week Low: 9,667.00
  • Currency: UK Pounds
  • Shares Issued: 1,550.91m
  • Volume: 3,650,493
  • Market Cap: £217,934m
  • RiskGrade: 123
  • Beta: 1.20
Select chart: 1 week | 1 month | 3 month | 1 year
 

Current

1 week

Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-25 58,660.61 18,444.75 683.31p 20.6 1.8 +11% 241.91p 0.0%
31-Dec-26 62,194.14 20,588.48 766.89p 18.3 1.5 +12% 254.67p 0.0%
31-Dec-27 65,845.97 22,790.20 856.51p 16.4 1.4 +12% 265.37p 0.0%

Copyright © 2026 FactSet Research Systems Inc. All rights reserved.

Trends & Recommendations

  Current 1 week ago 1 month ago 3 months ago 6 months ago 1 year ago
Revenue (£m)
31-Dec-2026 62,194 62,249 n/a 61,684 n/a 60,158
31-Dec-2027 65,846 65,900 n/a 65,210 n/a n/a
 
Earnings
31-Dec-2026 766.89p 767.01p n/a 770.43p n/a 854.57p
31-Dec-2027 856.51p 856.28p n/a 854.23p n/a n/a
 
Dividend
31-Dec-2026 254.67p 254.19p n/a 255.20p n/a 283.40p
31-Dec-2027 265.37p 264.87p n/a 267.16p n/a n/a
 
Recommendations
Strong Buy 10 10 10 0 0 9
Buy 13 13 13 0 0 14
Neutral 3 3 3 0 0 6
Sell 0 0 0 0 0 0
Strong Sell 1 1 1 0 0 0
No. of Brokers 27 27 27 0 0 29
 
Average Rec 7.87 7.87 7.87 n/a n/a 7.76

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Broker estimates sourced from FactSet Estimates +44 (0) 20 3009 7000. FactSet Estimates calculate consensus using only those estimates changed or actively validated within the last 75 days.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

AstraZeneca Market Data

Currency UK Pounds
Share Price 14,052.00p
Change Today 26.00p
% Change 0.19 %
52 Week High 14,346.00
52 Week Low 9,667.00
Volume 3,650,493
Shares Issued 1,550.91m
Market Cap £217,934m
Beta 1.20
RiskGrade 123

AstraZeneca Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
94.66% below the market average94.66% below the market average94.66% below the market average94.66% below the market average94.66% below the market average
90.24% below the sector average90.24% below the sector average90.24% below the sector average90.24% below the sector average90.24% below the sector average
Price Trend
9.16% above the market average9.16% above the market average9.16% above the market average9.16% above the market average9.16% above the market average
45.45% above the sector average45.45% above the sector average45.45% above the sector average45.45% above the sector average45.45% above the sector average
Income
68.72% below the market average68.72% below the market average68.72% below the market average68.72% below the market average68.72% below the market average
Sector averageSector averageSector averageSector averageSector average
Growth
87.64% above the market average87.64% above the market average87.64% above the market average87.64% above the market average87.64% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average

What The Brokers Say

Strong Buy 10
Buy 13
Neutral 3
Sell 0
Strong Sell 1
Total 27
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

AstraZeneca Dividends

  Latest Previous
  1st Interim 2nd Interim
Ex-Div 07-Aug-25 20-Feb-25
Paid 08-Sep-25 24-Mar-25
Amount 103.00¢ 210.00¢

Trades for 16-Jan-2026

Time Volume / Share Price
11:15 285,241 @ 14,020.00p
11:15 285,241 @ 14,020.00p
16:08 0 @ 14,050.00p
16:08 0 @ 14,050.00p
16:08 0 @ 14,050.00p

AstraZeneca Key Personnel

Chair Michel Demare

Top of Page